Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Niamh Appleby, David O’Brien, Fiona M. Quinn, Liam Smyth, Johanna Kelly, Imelda Parker, Kathleen Scott, Mary R. Cahill, Gerard Crotty, Helen Enright, Brian Hennessy, Andrew Hodgson, Maeve Leahy, Hilary O’Leary, Michael O’Dwyer, Amjad Hayat & Elisabeth A. Vandenberghe. (2018) Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL. Leukemia & Lymphoma 59:6, pages 1338-1347.
Read now
Read now
Marco Fangazio, Lorenzo De Paoli, Davide Rossi & Gianluca Gaidano. (2011) Predictive markers and driving factors behind Richter syndrome development. Expert Review of Anticancer Therapy 11:3, pages 433-442.
Read now
Read now
Ana P. Gonzalez-Rodriguez, Juan Contesti, Leticia Huergo-Zapico, Alejandro Lopez-Soto, Azahara Fernández-Guizán, Andrea Acebes-Huerta, Ana J. Gonzalez-Huerta, Esther Gonzalez, Carmen Fernandez-Alvarez & Segundo Gonzalez. (2010) Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia. Leukemia & Lymphoma 51:10, pages 1829-1836.
Read now
Read now
Hong-Xia Qiu, Wei Xu, Xiang-Shan Cao, Min Zhou, Yun-Feng Shen, Yan-Li Xu, Xue-Mei Sun, Qiong Liu, Rong Wang, Hai-Rong Qiu, Ji-Shi Wang & Jian-Yong Li. (2008) Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: A prospective, multicenter study on 143 cases analysed with interphase fluorescence hybridisation. Leukemia & Lymphoma 49:10, pages 1887-1892.
Read now
Read now
Articles from other publishers (28)
Paola Menichini, Paola Monti, Andrea Speciale, Giovanna Cutrona, Serena Matis, Franco Fais, Elisa Taiana, Antonino Neri, Riccardo Bomben, Massimo Gentile, Valter Gattei, Manlio Ferrarini, Fortunato Morabito & Gilberto Fronza. (2021) Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?. Cells 10:1, pages 98.
Crossref
Crossref
Yi Ding. 2021. Practical Oncologic Molecular Pathology. Practical Oncologic Molecular Pathology
339
359
.
Anna H. Schuh, Nilima Parry-Jones, Niamh Appleby, Adrian Bloor, Claire E. Dearden, Christopher Fegan, George Follows, Christopher P. Fox, Sunil Iyengar, Ben Kennedy, Helen McCarthy, Helen M. Parry, Piers Patten, Andrew R. Pettitt, Ingo Ringshausen, Renata Walewska & Peter Hillmen. (2018) Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology 182:3, pages 344-359.
Crossref
Crossref
Bhavana J. Davé & Warren G. Sanger. 2017. The AGT Cytogenetics Laboratory Manual. The AGT Cytogenetics Laboratory Manual
903
936
.
Erica Salaro, Alessia Rambaldi, Simonetta Falzoni, Francesca Saveria Amoroso, Alessia Franceschini, Alba Clara Sarti, Massimo Bonora, Francesco Cavazzini, Gian Matteo Rigolin, Maria Ciccone, Valentina Audrito, Silvia Deaglio, Pablo Pelegrin, Paolo Pinton, Antonio Cuneo & Francesco Di Virgilio. (2016) Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. Scientific Reports 6:1.
Crossref
Crossref
Enrique J. deAndrés-Galiana, Juan L. Fernández-Martínez, Oscar Luaces, Juan J. del Coz, Leticia Huergo-Zapico, Andrea Acebes-Huerta, Segundo González & Ana P. González-Rodríguez. (2016) Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems. Journal of Biomedical Informatics 60, pages 342-351.
Crossref
Crossref
Carolyn Owen, Isabelle Bence-Bruckler, Inès Chamakhi, Cynthia Toze, Wissam Assaily, Anna Christofides & Sue Robinson. (2015) A Canadian Perspective on the First-Line Treatment of Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 15:6, pages 303-313.
Crossref
Crossref
Li Tan, Li-Hua Xu, Hai-Bo Liu & Shao-Jiang Yang. (2015) Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia with Chromothripsis in an Old Woman. Chinese Medical Journal 128:7, pages 985-987.
Crossref
Crossref
Veronica Balatti, Yuri Pekarsky, Lara Rizzotto & Carlo M. Croce. 2013. MicroRNAs in Medicine. MicroRNAs in Medicine
383
401
.
Shang-Ju Wu, Chien-Ting Lin, Sheng-Yi Huang, Fen-Yu Lee, Ming-Chi Liu, Hsin-An Hou, Chien-Yuan Chen, Bor-Sheng Ko, Wen-Chien Chou, Ming Yao, Jih-Luh Tang, Woei Tsay & Hwei-Fang Tien. (2013) Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence—clinical implication and comparison between the West and the East. Annals of Hematology 92:6, pages 799-806.
Crossref
Crossref
April D. Sorrell, Carin R. Espenschied, Julie O. Culver & Jeffrey N. Weitzel. (2013) Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome. Molecular Diagnosis & Therapy 17:1, pages 31-47.
Crossref
Crossref
Albert J. Mach, Oladunni B. Adeyiga & Dino Di Carlo. (2013) Microfluidic sample preparation for diagnostic cytopathology. Lab on a Chip 13:6, pages 1011.
Crossref
Crossref
Veronica Balatti, Yuri Pekarky, Lara Rizzotto & Carlo M. Croce. 2013. Advances in Chronic Lymphocytic Leukemia. Advances in Chronic Lymphocytic Leukemia
309
325
.
L. Jeffrey Medeiros. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
867
918
.
Thomas SK WanEdmond SK Ma. (2012) The role of FISH in hematologic cancer. International Journal of Hematologic Oncology 1:1, pages 71-86.
Crossref
Crossref
André O. von Bueren, Joachim Gerss, Christian Hagel, Haoyang Cai, Marc Remke, Martin Hasselblatt, Burt G. Feuerstein, Sarah Pernet, Olivier Delattre, Andrey Korshunov, Stefan Rutkowski, Stefan M. Pfister & Michael Baudis. (2012) DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis. Journal of Neuro-Oncology 109:2, pages 415-423.
Crossref
Crossref
Jianming Pei, Suresh C. Jhanwar & Joseph R. Testa. (2012) Chromothripsis in a case of TP53-deficient chronic lymphocytic leukemia. Leukemia Research Reports 1:1, pages 4-6.
Crossref
Crossref
Christopher Moy, Catherine A Oleykowski, Ramona Plant, Joel Greshock, Junping Jing, Kurtis Bachman, Mary Ann Hardwicke, Richard Wooster & Yan Degenhardt. (2011) High Chromosome Number in hematological cancer cell lines is a Negative Predictor of Response to the inhibition of Aurora B and C by GSK1070916. Journal of Translational Medicine 9:1.
Crossref
Crossref
D. P. O’MALLEY, C. GIUDICE, A. S. CHANG, D. CHANG, T. S. BARRY, M. K. HIBBARD, R. CHEN & S.-T. CHEN. (2011) Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia. International Journal of Laboratory Hematology 33:3, pages 238-244.
Crossref
Crossref
Neil E. Kay, Jeanette E. Eckel-Passow, Esteban Braggio, Scott VanWier, Tait D. Shanafelt, Daniel L. Van Dyke, Diane F. Jelinek, Renee C. Tschumper, Thomas Kipps, John C. Byrd & Rafael Fonseca. (2010) Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy. Cancer Genetics and Cytogenetics 203:2, pages 161-168.
Crossref
Crossref
Susan O'Brien & Anders Österborg. (2010) Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 10:5, pages 361-368.
Crossref
Crossref
Zeynep A. Yegin, Zübeyde N. Özkurt & Münci Yağcı. (2010) Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia. European Journal of Haematology 84:5, pages 406-411.
Crossref
Crossref
Hirotake Nishimura, Takashi Akiyama, Yasumasa Monobe, Kiminori Matsubara, Yasuyuki Igarashi, Masafumi Abe, Takashi Sugihara & Yoshito Sadahira. (2010) Expression of sphingosine-1-phosphate receptor 1 in mantle cell lymphoma. Modern Pathology 23:3, pages 439-449.
Crossref
Crossref
Thorsten Zenz, Stefan Fröhling, Daniel Mertens, Hartmut Döhner & Stephan Stilgenbauer. (2010) Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL). Best Practice & Research Clinical Haematology 23:1, pages 71-84.
Crossref
Crossref
Anissa M. JabbourCarmel P. DauntBenjamin D. GreenSandra VogelLavinia GordonRachel S. Lee, Natasha SilkeRichard B. Pearson, Cassandra J. Vandenberg, Priscilla N. Kelly, Stephen L. Nutt, Andreas Strasser, Christoph BornerPaul G. Ekert. (2010) Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation. Blood 115:2, pages 344-352.
Crossref
Crossref
Michele Dal-Bo, Francesco Bertoni, Francesco Forconi, Antonella Zucchetto, Riccardo Bomben, Roberto Marasca, Silvia Deaglio, Luca Laurenti, Dimitar G Efremov, Gianluca Gaidano, Giovanni Del Poeta & Valter Gattei. (2009) Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. Journal of Translational Medicine 7:1.
Crossref
Crossref
A Farfsing, F Engel, M Seiffert, E Hartmann, G Ott, A Rosenwald, S Stilgenbauer, H Döhner, M Boutros, P Lichter & A Pscherer. (2009) Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia. Leukemia 23:11, pages 2018-2026.
Crossref
Crossref
Davide Rossi & Gianluca Gaidano. (2009) Richter syndrome: molecular insights and clinical perspectives. Hematological Oncology 27:1, pages 1-10.
Crossref
Crossref